Since the SCA1 cohort was characterized by distinct changes in Glc and Asp as opposed to SCA14, despite a significant shorter disease duration, these metabolites might point to metabolic pathways differing between SCA14 and SCA1. This evidence concerns the gene PRKCG and spinocerebellar ataxia type 14.